Finalist in the AstraZeneca ACCIÓN Program for Startups, Health Cluster(Madrid) – 04/02/2026
- Altum Sequencing

- Jun 4
- 1 min read
Named a finalist in AstraZeneca’s flagship acceleration program, "ACCIÓN," in collaboration with the regional Health Cluster. This selection underscores the company’s clinical relevance and its potential to establish strategic partnerships with the pharmaceutical industry to improve cancer patient outcomes.





Comments